HOME >> MEDICINE >> NEWS
Biopsy system is effective in completely removing benign breast masses

Benign breast masses can be safely and effectively removed without surgery--using a vacuum assisted breast biopsy system, preliminary results of a study show.

The study found that breast masses as large as 3 cm could be completely removed with just a small incision. The study included 24 patients, with 27 lesions, said Priscilla Slanetz, MD, director of breast imaging at Caritas St. Elizabeth's Medical Center in Boston, MA, a teaching affiliate Tufts University School of Medicine.

The patients were of various ages, and they had various reasons for wanting the benign masses removed, said Dr. Slanetz. Some had a strong family history of breast cancer and they were uncomfortable with any mass in their breast. Others wanted the mass removed because a known benign mass was enlarging. Some women opted for the procedure over surgery as they were poor surgical candidates due to other health problems, said Dr. Slanetz.

None of the patients had discomfort or pain and only one patient had a moderate amount of bleeding during the procedure. Following the procedure, only three patients had a moderate amount of pain relieved by Tylenol and three patients had a moderate amount of bruising, said Dr. Slanetz. All of the women have indicated that they would choose to have the procedure again," Dr. Slanetz said.

The procedure takes about 20-40 minutes, depending on the size of the mass, said Dr. Slanetz. That compares to a 30-60 minute surgical procedure, that includes anesthesia and a 1"-2" incision followed by stitches in the breast.

"We are still awaiting follow-up of the patients to see if there is any recurrence of their benign masses, but the preliminary results of this study are very positive," she said.

Dr. Slanetz will present her study on May 5 at the American Roentgen Ray Society Annual Meeting in Miami Beach, FL.


'"/>

Contact: Keri Sperry
keri@arrs.org
703-858-4306
American Roentgen Ray Society
5-May-2004


Page: 1

Related medicine news :

1. Misdiagnosis Looms As Demand Increases For New Breast Cancer Biopsy
2. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
3. Strengths and failings of U.S. health care system are driven by embedded vested interests
4. Physicists find patterns within seemingly random events of physiological systems
5. Chemists identify immune system mechanism for methamphetamine binges
6. Most hospital executives have substantial concerns about mandatory error reporting systems
7. New hand-held information system for emergency responders
8. Tumor-targeted immune cells cure prostate cancer in mice without causing systemic immune suppression
9. New NHS payment system is no panacea
10. Computerized order entry systems can increase risk of medication errors
11. New system for the analysis of facial movement in three dimensions

Post Your Comments:
(Date:8/1/2014)... 2014 Parker Waichman LLP, a national ... injured by defective medical devices and drugs reports that ... Ethicon surgical power morcellator devices used for the removal ... the spread of cancer associated with power morcellators, according ... 2014. , Johnson & Johnson had previously ceased ...
(Date:8/1/2014)... Aug. 1, 2014 (HealthDay News) -- Almost 140 ... school transportation in the United States. But ... bus-related catastrophes, Dawne Gardner, injury prevention coordinator at ... Center, said in a medical center news release. ... returning to school, it,s important for parents and ...
(Date:8/1/2014)... The evolving healthcare landscape presents ... At ThoughtSpot 2014, AmerisourceBergen and Good Neighbor Pharmacy’s ... resources to enhance patient care and profitability. At ... issues to give independent pharmacists the tools they ... ThoughtSpot show attendance experienced a nearly 70% increase ...
(Date:8/1/2014)... DC (PRWEB) August 01, 2014 ... Thompson (D-CA), Gregg Harper (R-MS), and Peter Welch ... 5380, the Medicare Telehealth Parity Act of 2014, ... fully support this effort to improve healthcare access ... chief executive officer of ATA. "These cost-saving provisions ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 On Monday, ... California NextGen User Symposium in San Francisco, CA. Now ... at the JW Marriott Union Square hotel. , “We ... get up to speed with ACA compliance issues,” Quirk ... month. The symposium provides attendees guidance with NextGen implementation ...
Breaking Medicine News(10 mins):Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 3Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 4Health News:Expert Offers School Bus Safety Tips 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
(Date:8/1/2014)... 1, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 3 study evaluating ISIS-SMN Rx in infants ... cause of infant mortality. Isis plans to dose the ... weeks, at which time Isis will earn an $18 ... The Phase 3 study, ENDEAR, is the first of ...
(Date:8/1/2014)... Pa. , Aug. 1, 2014 Inovio ... will host a conference call to report its second ... at 9:00 AM ET. CEO Dr. J. Joseph ... discuss second quarter earnings, provide a corporate update, and ... will include clinical development plans for VGX-3100, Inovio,s immune ...
(Date:8/1/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ... reported financial results for the second quarter ended ... continued to see encouraging advancements in the US ... in estimated total prescriptions and estimated total per ... Lief, Arena,s President and Chief Executive Officer. "Other ...
Breaking Medicine Technology:Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
Cached News: